Wendell David Associates Inc. Acquires 365 Shares of Synopsys, Inc. $SNPS

Wendell David Associates Inc. grew its holdings in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 32.7% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,482 shares of the semiconductor company’s stock after buying an additional 365 shares during the period. Wendell David Associates Inc.’s holdings in Synopsys were worth $760,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. HBW Advisory Services LLC boosted its holdings in shares of Synopsys by 494.9% during the 2nd quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company’s stock worth $1,851,000 after buying an additional 3,004 shares in the last quarter. Westbourne Investments Inc. bought a new position in shares of Synopsys during the 2nd quarter worth approximately $1,505,000. Bourgeon Capital Management LLC bought a new position in shares of Synopsys during the 2nd quarter worth approximately $451,000. North Star Asset Management Inc. grew its position in Synopsys by 3.6% in the 1st quarter. North Star Asset Management Inc. now owns 60,270 shares of the semiconductor company’s stock valued at $25,847,000 after purchasing an additional 2,082 shares during the period. Finally, SlateStone Wealth LLC grew its position in Synopsys by 467.8% in the 1st quarter. SlateStone Wealth LLC now owns 10,220 shares of the semiconductor company’s stock valued at $4,383,000 after purchasing an additional 8,420 shares during the period. 85.47% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, Director Robert G. Painter bought 350 shares of the business’s stock in a transaction on Thursday, September 11th. The stock was acquired at an average price of $425.44 per share, for a total transaction of $148,904.00. Following the purchase, the director directly owned 2,291 shares in the company, valued at $974,683.04. This trade represents a 18.03% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Sassine Ghazi sold 11,366 shares of the firm’s stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total value of $6,694,687.66. Following the completion of the transaction, the chief executive officer owned 71,615 shares of the company’s stock, valued at approximately $42,181,951.15. This represents a 13.70% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 30,894 shares of company stock worth $16,760,783 in the last 90 days. 0.62% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

SNPS has been the topic of a number of analyst reports. Mizuho lowered their target price on shares of Synopsys from $700.00 to $600.00 and set an “outperform” rating on the stock in a report on Thursday, September 11th. Baird R W cut shares of Synopsys from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 10th. Piper Sandler dropped their target price on shares of Synopsys from $660.00 to $630.00 and set an “overweight” rating on the stock in a research report on Wednesday, September 10th. BNP Paribas started coverage on shares of Synopsys in a report on Thursday, October 2nd. They issued an “underperform” rating and a $425.00 price target on the stock. Finally, Rosenblatt Securities reaffirmed a “neutral” rating and issued a $605.00 price target (down previously from $650.00) on shares of Synopsys in a report on Wednesday, September 10th. Ten research analysts have rated the stock with a Buy rating, five have given a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $569.67.

Get Our Latest Analysis on Synopsys

Synopsys Stock Up 1.7%

Shares of NASDAQ SNPS opened at $447.64 on Friday. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The business has a 50-day simple moving average of $525.72 and a two-hundred day simple moving average of $510.73. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52. The company has a market cap of $83.15 billion, a P/E ratio of 35.14, a P/E/G ratio of 4.93 and a beta of 1.10.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 EPS for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The company had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter in the prior year, the business earned $3.43 EPS. The firm’s revenue for the quarter was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Research analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

About Synopsys

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

See Also

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.